Suppr超能文献

锰超氧化物歧化酶免疫组化表达作为结直肠癌恶性潜能标志物的意义

Significance of immunohistochemical expression of manganese superoxide dismutase as a marker of malignant potential in colorectal carcinoma.

作者信息

Nozoe Tadahiro, Honda Masayuki, Inutsuka Sadaaki, Yasuda Mitshuhiro, Korenaga Daisuke

机构信息

Department of General Surgery, Fukuoka Dental College Hospital, Japan.

出版信息

Oncol Rep. 2003 Jan-Feb;10(1):39-43.

Abstract

Manganese superoxide dismutase (MnSOD) is an important superoxide anion scavenger located in mitochondria and protects cells from the damage caused by reactive oxygen species. The oxygen balance has been reported to be related to the occurrence and invasiveness of malignant tumors. The aim of the current study was to elucidate the clinicopathological significance of immunohistochemical MnSOD expression in colorectal carcinoma. Consecutive 186 primary colorectal carcinomas which had been resected from 1987 to 1999 were examined for MnSOD expression by means of an immunohistochemical investigation. Sixty nine carcinomas (37.1%) had a positive response to MnSOD. The proportion of lymph node metastasis in MnSOD positive carcinomas (49.3%, 34 out of 69) was significantly higher than that in MnSOD negative carcinomas (26.5%, 31 out of 117; p=0.002). The proportion of patients classified to Dukes' stage A, B, C, and D in MnSOD positive carcinomas was 10.1, 33.3, 40.7, and 15.9%, respectively, and those were 23.1, 49.5, 24.8, and 2.6%, respectively in MnSOD negative carcinomas (p=0.0001). The survival rate in patients with MnSOD positive carcinomas was significantly worse than that in patients with MnSOD negative carcinomas (p=0.01). Multivariate analysis demonstrated that Dukes' stage of tumors was found to be a factor independently associated with prognosis of the patients. Our results showed that immunohistochemical expression of MnSOD can give auxiliary clinical information for malignant potential of colorectal carcinoma.

摘要

锰超氧化物歧化酶(MnSOD)是一种位于线粒体中的重要超氧阴离子清除剂,可保护细胞免受活性氧物质造成的损伤。据报道,氧平衡与恶性肿瘤的发生和侵袭性有关。本研究的目的是阐明免疫组化检测MnSOD在结直肠癌中的表达的临床病理意义。通过免疫组化研究,对1987年至1999年间连续切除的186例原发性结直肠癌进行MnSOD表达检测。69例癌(37.1%)对MnSOD呈阳性反应。MnSOD阳性癌的淋巴结转移率(49.3%,69例中的34例)显著高于MnSOD阴性癌(26.5%,117例中的31例;p = 0.002)。MnSOD阳性癌中归类为Dukes分期A、B、C和D期的患者比例分别为10.1%、33.3%、40.7%和15.9%,而MnSOD阴性癌中分别为23.1%、49.5%、24.8%和2.6%(p = 0.0001)。MnSOD阳性癌患者的生存率显著低于MnSOD阴性癌患者(p = 0.01)。多因素分析表明,肿瘤的Dukes分期是与患者预后独立相关的因素。我们的结果表明,MnSOD的免疫组化表达可为结直肠癌的恶性潜能提供辅助临床信息。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验